TY - JOUR
T1 - An integrated care pathway for cancer patients with diabetes: A proposal from the Italian experience
AU - Gallo, Marco
AU - Clemente, Gennaro
AU - Cristiano Corsi, Domenico
AU - Michelini, Massimo
AU - Suraci, Concetta
AU - Farci, Daniele
AU - Chantal Ponziani, Maria
AU - Candido, Riccardo
AU - Russo, Antonio
AU - Musacchio, Nicoletta
AU - Pinto, Carmine
AU - Mannino, Domenico
AU - Gori, Stefania
PY - 2019/5/11
Y1 - 2019/5/11
N2 - Diabetes and cancer frequently coexist in the same subject, often with relevant clinical effects on the management and prognosis of the comorbid patient. The existing guidelines, however, do not appropriately address many clinical issues in this setting. Although collaboration between diabetologists and oncologists should play an important role in achieving appropriate levels of care, close coordination or agreement between these specialists is seldom offered. There is an urgent need for greater interdisciplinary integration between all specialists involved in this setting, for a shared approach ensuring that organisational silos are overcome. To this end, the Italian Associations of Medical Diabetologists (AMD) and the Italian Association of Medical Oncology (AIOM) recently established a dedicated Working Group on ‘Diabetes and Cancer’. The working group outlined a diagnostic and therapeutic clinical pathway dedicated to hospitalised patients with diabetes and cancer. In this article, we describe the Italian proposal including some suggested measures to assess, monitor and improve blood glucose control in the hospital setting, to integrate different specialists from both areas, as well as to ensure discharge planning and continuity of care from the hospital to the territory.
AB - Diabetes and cancer frequently coexist in the same subject, often with relevant clinical effects on the management and prognosis of the comorbid patient. The existing guidelines, however, do not appropriately address many clinical issues in this setting. Although collaboration between diabetologists and oncologists should play an important role in achieving appropriate levels of care, close coordination or agreement between these specialists is seldom offered. There is an urgent need for greater interdisciplinary integration between all specialists involved in this setting, for a shared approach ensuring that organisational silos are overcome. To this end, the Italian Associations of Medical Diabetologists (AMD) and the Italian Association of Medical Oncology (AIOM) recently established a dedicated Working Group on ‘Diabetes and Cancer’. The working group outlined a diagnostic and therapeutic clinical pathway dedicated to hospitalised patients with diabetes and cancer. In this article, we describe the Italian proposal including some suggested measures to assess, monitor and improve blood glucose control in the hospital setting, to integrate different specialists from both areas, as well as to ensure discharge planning and continuity of care from the hospital to the territory.
KW - Clinical pathways
KW - Diabetes and cancer
KW - Inpatient diabetes care
KW - Inpatient hyperglycaemia
KW - Oncology
UR - http://www.scopus.com/inward/record.url?scp=85065839833&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85065839833&partnerID=8YFLogxK
U2 - 10.1016/j.diabres.2019.04.036
DO - 10.1016/j.diabres.2019.04.036
M3 - Editorial
C2 - 31085198
AN - SCOPUS:85065839833
JO - Diabetes Research and Clinical Practice
JF - Diabetes Research and Clinical Practice
SN - 0168-8227
ER -